Key result
Same-day discharge after balloon pulmonary angioplasty was feasible and not associated with a significant increase in 30-day readmission or mortality compared to overnight observation.
Why the study?
Overnight observation is standard practice after BPA for inoperable or residual chronic thromboembolic pulmonary hypertension, leading investigators to evaluate the safety and feasibility of same-day discharge.
Does same-day discharge after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension increase 30-day readmission, mortality, or complications compared to overnight observation?
Cohort (n=77)
No
Does same-day discharge after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension increase 30-day readmission, mortality, or complications compared to overnight observation?
Same-day discharge after balloon pulmonary angioplasty for CTEPH is feasible and appears safe when guided by a structured selection algorithm, potentially optimizing resource utilization.
Answers are grounded in this paper and cite their sources.
Supports same-day discharge feasibility in selected CTEPH patients after BPA; hypothesis-generating pending randomized confirmation.
Background: Balloon pulmonary angioplasty (BPA) is increasingly used for patients with inoperable or residual chronic thromboembolic pulmonary hypertension. Overnight observation is the current standard practice. We evaluated the safety and feasibility of same-day discharge (SDD) after BPA at a contemporary US referral center. Methods: We retrospectively analyzed consecutive chronic thromboembolic pulmonary hypertension patients undergoing BPA between 2018 and 2024. SDD was defined as discharge on the calendar day of BPA. The primary outcome was 30-day readmission or mortality; secondary outcomes included BPA-related complications. Predictors of SDD were assessed using mixed-effects logistic regression. Conclusions: Among patients meeting prespecified institutional eligibility criteria, SDD after BPA was feasible and not associated with increased 30-day adverse events. Structured SDD pathways guided by reproducible selection criteria may optimize resource utilization as BPA volumes continue to grow.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) conducted a cohort in Chronic thromboembolic pulmonary hypertension (CTEPH) (n=77). Same-day discharge vs. Overnight or longer hospitalization was evaluated on 30-day readmission or mortality (p=0.43). Same-day discharge after balloon pulmonary angioplasty was feasible and not associated with a significant increase in 30-day readmission or mortality compared to overnight observation.
Synapse has enriched 10 related papers. Consider them for comparative context: